Bayer Healthcare Unit Says Eyes Takeovers In India


Bayer, Germany's largest drugmaker, is looking for acquisitions to bolster its fledgling healthcare business in India.
Bayer's healthcare division generated more than 20% of 2009 sales in the Asia Pacific region, where it saw faster growth than in any other region. While it is one of the largest pharmaceuticals suppliers in China, its presence in the Indian drug market has been of little significance.
"In India we are open to businesses to strengthen our position," said Alok Kanti, in charge of Bayer's Asia Pacific prescription drug division, adding the company was "looking for the right opportunity and evaluating every opportunity."
Consultancy McKinsey & Co expects India's drug market to swell to about $20 billion in revenues in 2015, growing at an annual 12-14%. Bayer's business in India has so far been dominated by its CropScience pesticides unit.
Chief executive Werner Wenning has repeatedly said he was looking for takeovers to strengthen Bayer's healthcare division but larger deals were seen as unlikely before he hands over to his successor Marijn Dekkers in October.
Company
Bayer AG
51368 Leverkusen
Germany
most read

Arkema Launches Acrylic Acid Purification Project
Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Boehringer Ingelheim Paves the Way for Important Market Launches
Boehringer Ingelheim recorded positive growth in the first half of 2025 with an increase in Group sales of 6.3% to € 14 billion.

Novo Nordisk Invests $1.09 Billion in Brazil
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.

BASF Divests Two Joint Ventures in China
BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Ineos Invests £30 Million to Slash Emissions at Hull Site by 75%
Ineos has completed a major £30 million investment at its Hull manufacturing site, converting the facility to run on clean-burning hydrogen instead of natural gas. This results in a 75% cut in carbon emissions.